Background: People with type 2 diabetes are more vulnerable to infections due to a weakened immune system caused by diabetes-related factors. Urinary tract infections caused by bacteria are associated with antibiotic resistance and severe recurrent disease. Methods: This cross-sectional study characterized uropathogenic bacteria and assessed beta-lactamases linked to antibiotic resistance with a sample size of 294. In this research, bacteria from urine culture were identified by mass spectrometry-MALDI-TOF-MS and standard biochemical assays. A phenotypic confirmatory disc diffusion test (PCDDT) was utilized to assess Extended Spectrum Beta Lactamase (ESBL) generating isolates. Results: The prevalence of Urinary Tract Infection was 11% (n = 294). Prevalence was significantly higher in those with a mean Random Blood Sugar (RBS) of >190 g/dl (13.1%) than in those with a mean RBS of ≤190 g/dl (X2: p = 0.029). The prevalence of UTIs was also significantly higher among traders (29%, X2: p = 0.019) than among employed (16.6%) and unemployed (7.2%) participants. UTI prevalence was significantly higher among those with type 2 diabetes between 5 and 10 years since medical diagnosis (17%, X2: p = 0.029) than among those diagnosed < 5 years. The most isolated bacteria were E. coli (43.8%), Klebsiella spp. (34.4%), and Enterobacter spp. (12.5%). E. coli exhibited the highest level of antibiotic resistance, including resistance to 3rd generation Cephalosporin. Phenotypic ESBL confirmatory test showed 62.5% of the E. coli being positive for ESBL production. Conclusion: UTIs were common in type 2 diabetics, especially in those with >190 g/dl mean RBS. There was a concerning 62.5% ESBL-producing E. coli that were resistant to antibiotics, which is a serious threat to public health. Thus, regular UTI screening and AST should be utilized before prescription to facilitate Antibiotic resistance surveillance and promote early diagnosis, treatment, and infection control.
References
[1]
World Health Organization (2016) Global Report on Diabetes. https://www.who.int/publications/i/item/9789241565257
[2]
International Diabetes Federation Diabetes (2019) IDF Diabetes Atlas. https://diabetesatlas.org/upload/resources/material/20200302_133351_IDFATLAS9e-final-web.pdf
[3]
Msyamboza, K.P., Mvula, C.J. and Kathyola, D. (2014) Prevalence and Correlates of Diabetes Mellitus in Malawi: Population-Based National NCD STEPS Survey. BMC Endocrine Disorders, 14, Article No. 41. https://doi.org/10.1186/1472-6823-14-41
[4]
Toniolo, A., Cassani, G., Puggioni, A., Rossi, A., Colombo, A., Onodera, T. and Ferrannini, E. (2019) The Diabetes Pandemic and Associated Infections: Suggestions for Clinical Microbiology. Reviews in Medical Microbiology, 30, 1-17. https://doi.org/10.1097/MRM.0000000000000155
[5]
Sajid, M., Akash, H., Rehman, K., Fiayyaz, F., Sabir, S. and Khurshid, M. (2020) DiabetesAssociated Infections: Development of Antimicrobial Resistance and Possible Treatment Strategies. Archives of Microbiology, 202, 953-965. https://doi.org/10.1007/s00203-020-01818-x
[6]
Martins, M., Boavida, J.M., Raposo, J.F., Froes, F., Nunes, B., Ribeiro, R.T., Macedo, M.P. and Penha-Gonçalves, C. (2016) Diabetes Hinders Community-Acquired Pneumonia Outcomes in Hospitalized Patients. BMJ Open Diabetes Research and Care, 4, e000181. https://doi.org/10.1136/bmjdrc-2015-000181
[7]
Unnikrishnan, R. and Misra, A. (2020) Infections and Diabetes: Risks and Mitigation with Reference to India. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14, 1889-1894. https://doi.org/10.1016/j.dsx.2020.09.022
[8]
Vignera, S.L., Condorelli, R.A., Cannarella, R., Giacone, F., Mongioi, L.M., Cimino, L., Defeudis, G., Mazzilli, R. and Calogero, A.E. (2019) Urogenital Infections in Patients with Diabetes Mellitus: Beyond the Conventional Aspects. International Journal of Immunopathology and Pharmacology, 33, 1-6. https://doi.org/10.1177/2058738419866582
[9]
Woldemariam, H.K., Geleta, D.A., Tulu, K.D., Aber, N.A., Legese, M.H., Fenta, G.M. and Ali, I. (2019) Common Uropathogens and Their Antibiotic Susceptibility Pattern among Diabetic Patients. BMC Infectious Diseases, 5, 1-10. https://doi.org/10.1186/s12879-018-3669-5
[10]
Youssouf Kani Elmi, S., Saber Ashour, M., Zakaria Alsewy, F. and Fawzy Abd El Moez Azzam, N. (2021) Phenotypic and Genotypic Detection of Extended Spectrum Β-Lactamases among Escherichia Coli and Klebsiella Pneumoniae Isolates from Type 2 Diabetic Patients with Urinary Tract Infections. African Health Sciences, 21, 497-504. https://doi.org/10.4314/ahs.v21i2.3
[11]
Adu-Poku, M. and Addo, M.G. (2020) Antimicrobial Susceptibility Profile of Urinary Tract Pathogenic Infections in Diabetic Patients Attending a Health Facility in Kumasi, Ghana. International Journal of Pathogen Research, 4, 37-45. https://doi.org/10.9734/ijpr/2020/v4i230109
[12]
Asamoah-Boaheng, M., Sarfo-Kantanka, O., Tuffour, A.B., Eghan, B. and Mbanya, J.C. (2019) Prevalence and Risk Factors for Diabetes Mellitus among Adults in Ghana: A Systematic Review and Meta-Analysis. International Health, 11, 83-92. https://doi.org/10.1093/inthealth/ihy067
[13]
Grandy, S., Fox, K.M. and Hardy, E. (2013) Prevalence and Recurrence of Urinary Tract and Genital Infections among Adults with and without Type 2 Diabetes Mellitus in the General Population: A Longitudinal Cohort Study. Journal of Diabetes Research & Clinical Metabolism, 1-8.
[14]
Nigussie, D. and Amsalu, A. (2017) Prevalence of Uropathogen and Their Antibiotic Resistance Pattern among Diabetic Patients. Turk Uroloji Dergisi, 43, 85-92.
[15]
Nitzan, O., Elias, M., Chazan, B. and Saliba, W. (2015) Urinary Tract Infections in Patients with Type 2 Diabetes Mellitus: Review of Prevalence, Diagnosis, and Management. Diabetes, Metabolic Syndrome and Obesity, 8, 129-136. https://doi.org/10.2147/DMSO.S51792
[16]
Almugadam, B.S., Ibrahim, M.K., Liu, Y., Chen, S., Wang, C., et al. (2021) Association of Urogenital and Intestinal Parasitic Infections with Type 2 Diabetes Individuals: A Comparative Study. BMC Infectious Diseases, 21, Article No. 20. https://doi.org/10.1186/s12879-020-05629-9
[17]
Alemu, M., Belete, M.A., Gebreselassie, S., Belay, A. and Gebretsadik, D. (2020) Bacterial Profiles and Their Associated Factors of Urinary Tract Infection and Detection of Extended Spectrum Beta-Lactamase Producing Gram-Negative Uropathogens among Patients with Diabetes Mellitus at Dessie Referral Hospital, Northeastern Ethiopia. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 13, 2935-2948. https://doi.org/10.2147/dmso.s262760
Gutema, T., Weldegebreal, F., Marami, D. and Teklemariam, Z. (2018) Prevalence, Antimicrobial Susceptibility Pattern, and Associated Factors of Urinary Tract Infections among Adult Diabetic Patients at Metu Karl Heinz Referral Hospital, Southwest Ethiopia. International Journal of Microbiology, 2018, Article 7591259. https://doi.org/10.1155/2018/7591259
[20]
Abu-Ashour, W., Twells, L.K., Valcour, J.E. and Gamble, J.M. (2018) Diabetes and the Occurrence of Infection in Primary Care: A Matched Cohort Study. BMC Infectious Diseases, 18, Article No. 67. https://doi.org/10.1186/s12879-018-2975-2
[21]
Anis, A. and Chaudhary, A. (2018) Urinary Tract Infections Caused by ESBL Producing E. coli in Diabetes Mellitus: Alternative Approaches for Treatment and Management. International Journal of Pharma Professional’s Research, 11, 119-132. https://ijppr.humanjournals.com/wp-content/uploads/2018/02/11.Anis-Ahmad-Chaudhary.pdf
[22]
Bertakis, K.D., Azari, R., Helms, L.J., Callahan, E.J. and Robbins, J.A. (2000) Gender Differences in the Utilization of Health Care Services. The Journal of Family Practice, 49, 147-152
[23]
Ek, S. (2015) Gender Differences in Health Information Behaviour: A Finnish Population-Based Survey. Health Promotion International, 30, 736-745. https://doi.org/10.1093/heapro/dat063
[24]
Olanrewaju, F.O., Ajayi, L.A., Loromeke, E., Olanrewaju, A., Allo, T. and Nwannebuife, O. (2019) Masculinity and Men’s Health-Seeking Behaviour in Nigerian Academia. CogentSocial Sciences, 5, Article 1682111. https://doi.org/10.1080/23311886.2019.1682111
[25]
Salari, N., Karami, M.M., Bokaee, S., Chaleshgar, M., Shohaimi, S., Akbari, H. and Mohammadi, M. (2022) The Prevalence of Urinary Tract Infections in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis. European Journal of Medical Research, 27, Article No. 20. https://doi.org/10.1186/s40001-022-00644-9
[26]
Chang, C.H., Wang, J.L., Wu, L.C., Chuang, L.M. and Lin, H.H. (2019) Diabetes, Glycemic Control, and Risk of Infection Morbidity and Mortality: A Cohort Study. Open Forum Infectious Diseases, 6, ofz358. https://doi.org/10.1093/ofid/ofz358
[27]
Carey, I.M., Critchley, J.A., Dewilde, S., Harris, T., Hosking, F.J. and Cook, D.G. (2018) Risk of Infection in Type 1 and Type 2 Diabetes Compared with the General Population: A Matched Cohort Study. Diabetes Care, 41, 513-521. https://doi.org/10.2337/dc17-2131
[28]
Mehrabi, M., Salehi, B., Rassi, H. and Dehghan, A. (2020) Evaluating the Antibiotic Resistance and Frequency of Adhesion Markers among Escherichia Coli Isolated from Type 2 Diabetes Patients with Urinary Tract Infection and Its Association with Common Polymorphism of Mannose-Binding Lectin Gene. New Microbes and New Infections, 38, Article 100827. https://doi.org/10.1016/j.nmni.2020.100827
[29]
Hendriks-Spoor, K.D., Wille, F.L., Doesschate, T.T., Dorigo-Zetsma, J.W., Verheij, T.J.M. and van Werkhoven, C.H. (2022) Five Versus Seven Days of Nitrofurantoin for Urinary Tract Infections in Women with Diabetes: A Retrospective Cohort Study. Clinical Microbiology and Infection, 28, 377-382. https://doi.org/10.1016/j.cmi.2021.06.034
[30]
Chan, J.C., Cockram, C.S. and Critchley, J.A. (1996) Drug-Induced Disorders of Glucose Metabolism. Mechanisms and Management. Drug Safety, 15, 135-157. https://doi.org/10.2165/00002018-199615020-00005
[31]
Ray, C., Wu, V.C., Wang, C., Tu, H. and Huang, Y. (2021) Hypoglycemia Associated with Drug-Drug Interactions in Patients with Type 2 Diabetes Mellitus Using Dipeptidylpeptidase-4 Inhibitors. Frontiers in Pharmacology, 12, 1-8. https://doi.org/10.3389/fphar.2021.570835
[32]
May, M. and Schindler, C. (2016) Clinically and Pharmacologically Relevant Interactions of Antidiabetic Drugs. Therapeutic Advances in Endocrinology and Metabolism, 7, 69-83.
[33]
Munar, M.Y. and Singh, H. (2007) Drug Dosing Adjustments in Patients with Chronic Kidney Disease. American Academy of Family Physicians, 75, 1487-1496.
[34]
Seifu, W.D. and Gebissa, A.D. (2018) Prevalence and Antibiotic Susceptibility of Uropathogens from Cases of Urinary Tract Infections (UTI) in Shashemene Referral Hospital, Ethiopia. BMC Infectious Diseases, 18, Article No. 30. https://doi.org/10.1186/s12879-017-2911-x
[35]
Ugwu, M.C., Shariff, M., Nnajide, C.M., Beri, K., Okezie, U.M., Iroha, I.R. and Esimone, C.O. (2020) Phenotypic and Molecular Characterization of β-Lactamases among Enterobacterial Uropathogens in Southeastern Nigeria. The Canadian Journal of Infectious Diseases & Medical Microbiology, 2020, Article 5843904. https://doi.org/10.1155/2020/5843904
[36]
Naqid, I.A., Balatay, A.A., Hussein, N.R., Saeed, K.A., Ahmed, H.A. and Yousif, S.H. (2020) Antibiotic Susceptibility Pattern of Escherichia coli Isolated from Various Clinical Samples in Duhok City, Kurdistan Region of Iraq. International Journal of Infection, 7, 3-7. https://doi.org/10.5812/iji.103740
[37]
Daoud, N., Hamdoun, M., Hannachi, H., Gharsallah, C., Mallekh, W. and Bahri, O. (2020) Antimicrobial Susceptibility Patterns of Escherichia coli among Tunisian Outpatients with Community-Acquired Urinary Tract Infection (2012-2018). Current Urology, 14, 200-205. https://doi.org/10.1159/000499238
[38]
Ayukekbong, J.A., Ntemgwa, M. and Atabe, A.N. (2017) The Threat of Antimicrobial Resistance in Developing Countries: Causes and Control Strategies. Antimicrobial Resistance and Infection Control, 6, Article No. 47. https://doi.org/10.1186/s13756-017-0208-x
[39]
Salam, M.A., Al-Amin, M.Y., Salam, M.T., Pawar, J.S., Akhter, N., Rabaan, A.A. and Alqumber, M.A.A. (2023) Antimicrobial Resistance: A Growing Serious Threat for Global Public Health. Healthcare, 11, Article 1946. https://doi.org/10.3390/healthcare11131946
[40]
Ahmed, I., Rabbi, B. and Sultana, S. (2019) Antibiotic Resistance in Bangladesh: A Systematic Review. International Journal of Infectious Diseases, 80, 54-61. https://www.sciencedirect.com/science/article/pii/S1201971219300086 https://doi.org/10.1016/j.ijid.2018.12.017
[41]
Teklu, D.S., Negeri, A.A., Legese, M.H., Bedada, T.L., Woldemariam, H.K. and Tullu, K.D. (2019) Extended-Spectrum Beta-Lactamase Production and Multi-Drug Resistance among Enterobacteriaceae Isolated in Addis Ababa, Ethiopia. Antimicrobial Resistance & Infection Control, 8, Article No. 39. https://doi.org/10.1186/s13756-019-0488-4
[42]
Erb, S., D’Mello-Guyett, L., Malebo, H.M., Njee, R.M., Matwewe, F., Ensink, J., Hinic, V., Widmer, A. and Frei, R. (2018) High Prevalence of ESBL-Producing E. Coli in Private and Shared Latrines in an Informal Urban Settlement in Dar es Salaam, Tanzania. Antimicrobial Resistance & Infection Control, 7, Article No. 3. https://doi.org/10.1186/s13756-017-0292-y
[43]
Gaviria, L.P., Montsant, L., Azuaje, C., González-Díaz, A., Horcajada, J.P., Limón, E., Viñas, M., Espinal, P. and Fusté, E.A. (2022) Descriptive Analysis of Urinary ESBL-Producing-Escherichia coli in Cerdanya Hospital. Microorganisms, 10, Article 488. https://doi.org/10.3390/microorganisms10030488
[44]
Jia, P., Zhu, Y., Li, X., Kudinha, T., Yang, Y., Zhang, G., Zhang, J., Xu, Y. and Yang, Q. (2021) High Prevalence of Extended-Spectrum Beta-Lactamases in Escherichia coli Strains Collected from Strictly Defined Community-Acquired Urinary Tract Infections in Adults in China: A Multicenter Prospective Clinical Microbiological and Molecular Study. Frontiers in Microbiology, 12, Article 663033. https://doi.org/10.3389/fmicb.2021.663033
[45]
Mahmud, Z.H., Kabir, M.H., Ali, S., Moniruzzaman, M., Imran, K.M., Nafiz, T.N., Islam, M.S., Hussain, A., Hakim, S.A.I., Worth, M., Ahmed, D., Johnston, D. and Ahmed, N. (2020) Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Drinking Water Samples from a Forcibly Displaced, Densely Populated Community Setting in Bangladesh. Frontiers in Public Health, 8, Article 228. https://doi.org/10.3389/fpubh.2020.00228
[46]
Carrillo-Larco, R.M., Anza-Ramírez, C., Saal-Zapata, G., Villarreal-Zegarra, D., Zafra-Tanaka, J.H., Ugarte-Gil, C. and Bernabé-Ortiz, A. (2021) Type 2 Diabetes Mellitus and Antibiotic-Resistant Infections: A Systematic Review and Meta-Analysis. Journal of Epidemiology and Community Health, 76, 75-84. https://doi.org/10.1136/jech-2020-216029
[47]
Darphorn, T.S., Bel, K., Koenders-van Sint Anneland, B.B., et al. (2021) Antibiotic Resistance Plasmid Composition and Architecture in Escherichia coli Isolates from Meat. Scientific Reports, 11, Article No. 2136. https://doi.org/10.1038/s41598-021-81683-w
[48]
Castanheira, M., Simner, P.J. and Bradford, P.A. (2021) Extended-Spectrum β-Lactamases: An Update on Their Characteristics, Epidemiology and Detection. JAC-Antimicrobial Resistance, 3, dlab092. https://doi.org/10.1093/jacamr/dlab092
[49]
Mirnezami, M., Ranjbar, R., Niakan, M. and Ahmadi, M.H. (2020) Frequency of Antimicrobial Resistance and Class 1 and 2 Integrons in Escherichia Coli Strains Isolated from Urinary Tract Infections. Iranian Journal of Pharmaceutical Research, 19, 282-287.
